These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20921133)

  • 1. The two faces of serotonin in bone biology.
    Ducy P; Karsenty G
    J Cell Biol; 2010 Oct; 191(1):7-13. PubMed ID: 20921133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
    Yadav VK; Ryu JH; Suda N; Tanaka KF; Gingrich JA; Schütz G; Glorieux FH; Chiang CY; Zajac JD; Insogna KL; Mann JJ; Hen R; Ducy P; Karsenty G
    Cell; 2008 Nov; 135(5):825-37. PubMed ID: 19041748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrp5 and bone formation : A serotonin-dependent pathway.
    Yadav VK; Ducy P
    Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin rising--the bone, brain, bowel connection.
    Rosen CJ
    N Engl J Med; 2009 Mar; 360(10):957-9. PubMed ID: 19264685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intestinal serotonin and regulation of bone mass].
    Oury F; Karsenty G
    Med Sci (Paris); 2009 May; 25(5):445-6. PubMed ID: 19480820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of bone remodeling by nervous system. The role of serotonin in the regulation of bone metabolism].
    Inose H
    Clin Calcium; 2010 Dec; 20(12):1850-956. PubMed ID: 21123937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.
    Baron R; Rawadi G
    Endocrinology; 2007 Jun; 148(6):2635-43. PubMed ID: 17395698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lrp5 functions in bone to regulate bone mass.
    Cui Y; Niziolek PJ; MacDonald BT; Zylstra CR; Alenina N; Robinson DR; Zhong Z; Matthes S; Jacobsen CM; Conlon RA; Brommage R; Liu Q; Mseeh F; Powell DR; Yang QM; Zambrowicz B; Gerrits H; Gossen JA; He X; Bader M; Williams BO; Warman ML; Robling AG
    Nat Med; 2011 Jun; 17(6):684-91. PubMed ID: 21602802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signaling: a key regulator of bone mass.
    Baron R; Rawadi G; Roman-Roman S
    Curr Top Dev Biol; 2006; 76():103-27. PubMed ID: 17118265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin: a messenger between the brain/small intestine and the skeleton. Animal models strengthen the hypothesis about the role of serotonin in bone formation].
    Lerner UH; Ohlsson C; Ahlman H; Mellström D
    Lakartidningen; 2011 Mar 16-22; 108(11):600-5. PubMed ID: 21516677
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of bone mass by serotonin: molecular biology and therapeutic implications.
    Karsenty G; Yadav VK
    Annu Rev Med; 2011; 62():323-31. PubMed ID: 21073335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of bone metabolism by pathogenic mutations and polymorphism in the LRP5-Wnt signaling genes].
    Urano T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():95-100. PubMed ID: 18161089
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of serotonin inhibition in mouse models of bone loss.
    Inose H; Zhou B; Yadav VK; Guo XE; Karsenty G; Ducy P
    J Bone Miner Res; 2011 Sep; 26(9):2002-11. PubMed ID: 21608033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT and bone biology.
    Ducy P
    Curr Opin Pharmacol; 2011 Feb; 11(1):34-8. PubMed ID: 21320797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When the gut talks to bone.
    Long F
    Cell; 2008 Nov; 135(5):795-6. PubMed ID: 19041744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
    Glass DA; Karsenty G
    Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.